MedTrace Logo

Medically Tailored Meals to Reduce Ultra-processed Food Intake in Colorectal Cancer Survivors

NCT07701707 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-07-14

No results posted yet for this study

Summary

This research study is a three-arm, parallel-group randomized clinical trial that examines the feasibility and initial impact of consuming medically tailored meals to reduce intake of ultra-processed food and improve health and survival outcomes among 60 patients with stage I-III colorectal cancer.

Conditions

  • Colorectal Cancer (Diagnosis)

Interventions

BEHAVIORAL

MTM: Medically tailored meals

3 fully prepared, home-delivered, medically tailored meals per day delivered weekly for 6 weeks.

BEHAVIORAL

MTM plus Fresh Produce

2 fully prepared, home-delivered, medically tailored meals per day, plus weekly deliveries of fresh produce and accompanying recipes, for 6 weeks.

BEHAVIORAL

Control group

weekly recipes and meal-planning materials only; no food will be provided.

Sponsors & Collaborators

Principal Investigators

  • Mengxi Du, RD, PhD, MPH · Massachusetts General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-10
Primary Completion
2028-08-10
Completion
2028-10-10

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07701707 on ClinicalTrials.gov